Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$31.15 - $33.39 $331,280 - $355,102
10,635 Added 8.59%
134,419 $4.46 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $2.37 Million - $2.58 Million
76,773 Added 163.31%
123,784 $3.9 Million
Q2 2022

Aug 15, 2022

BUY
$23.75 - $31.69 $1.12 Million - $1.49 Million
47,011 New
47,011 $1.43 Million
Q4 2020

Feb 16, 2021

SELL
$15.73 - $21.66 $3.05 Million - $4.2 Million
-193,880 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$13.54 - $26.41 $1.34 Million - $2.62 Million
99,109 Added 104.58%
193,880 $3.29 Million
Q2 2020

Aug 14, 2020

BUY
$7.84 - $23.29 $743,004 - $2.21 Million
94,771 New
94,771 $2.21 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.